{ "@type": "Dataset", "name": "@parulia on X", "description": "Followers, posts and engagement for @parulia.", "url": "https://tweetindex.com/account/parulia", "isAccessibleForFree": true, "creator": { "@id": "https://tweetindex.com/#organization" }, "variableMeasured": [ { "@type": "PropertyValue", "name": "Followers", "value": 11584 }, { "@type": "PropertyValue", "name": "Following", "value": 3636 }, { "@type": "PropertyValue", "name": "Posts", "value": 4811 }, { "@type": "PropertyValue", "name": "Collected posts", "value": 7 }, { "@type": "PropertyValue", "name": "Views on collected posts", "value": 548865 }, { "@type": "PropertyValue", "name": "Likes on collected posts", "value": 1656 } ], "distribution": [ { "@type": "DataDownload", "contentUrl": "https://tweetindex.com/api/accounts/parulia", "encodingFormat": "application/json" } ], "@id": "https://tweetindex.com/account/parulia#dataset" }

parul ✓

@parulia · San Francisco, CA · joined 03 Apr 2007

partner + builder @645ventures | investing in AI agents, dev tools, and infrastructure | previously @initialized @fcollective @mit | here to help founders win

11 584Followers

3 636Following

4 811Posts total

548.9KViews on collected posts

Postingan terbaru

parul ✓@parulia10 Sep

love this (b2b marketing) energy 🎤 898 views · 5 likes · 0 reposts · 0 replies Open on X →

parul ✓@parulia7 Sep

The FDA was sluggish long before AI. Now the mismatch is lethal. Life-saving drugs and devices are arriving faster than the paperwork. The regulatory wall between discovery and patients is about to look indefensible. 396 views · 0 likes · 0 reposts · 0 replies Open on X →

parul ✓@parulia7 Sep

“We are facing a transition to a world with incredibly intelligent machines, and we need to ensure that transition works out well for humanity. We need to find ways to preserve human agency and enshrine an intrinsic value to being human, in a world where most tasks could be 504 views · 1 likes · 0 reposts · 1 replies Open on X →

parul ✓@parulia5 Sep

good discussion on AGI and if we’re there 520 views · 1 likes · 0 reposts · 0 replies Open on X →

parul ✓@parulia4 Sep

https://t.co/6DJbHpa1Fx 6.3K views · 46 likes · 0 reposts · 2 replies Open on X →

parul ✓@parulia4 Sep

We are on the cusp of a wave of new therapies for some of the worst diseases. But the world won’t benefit unless the US fixes its drug regulatory system. My new essay for @nytimes, on how slow clinical trials are now the biggest obstacle to curing cancer. https://t.co/XaHdduaaQN 539.9K views · 1.6K likes · 410 reposts · 82 replies Open on X →

parul ✓@parulia3 Sep

Used to be said for software: quality, speed, cost - pick 2 Always been true for investments: price, ownership, derisked - pick 2 359 views · 5 likes · 0 reposts · 1 replies Open on X →

Dibandingkan akun berukuran sama

7 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. jangkauan biasa untuk ukurannya, reaksi lebih lemah dari kebanyakan.

Median tayangan520akun ini924median untuk 10K–100K

Jangkauan, %4.49%akun ini3.62%median untuk 10K–100K

Interaksi, %0.40%akun ini1.52%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	520	924	0.56×
Jangkauan (tayangan ÷ pengikut)	4.49%	3.62%	1.24×
Tingkat interaksi	0.40%	1.52%	0.26×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.